Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic. (2022)

• Record Type: Journal Article
• Authors: Killelea, Amy; Johnson, Jeremiah; Dangerfield, Derek T.; Beyrer, Chris; McGough, Matthew; McIntyre, John; Gee, Rebekah E.; Ballreich, Jeromie; Conti, Rena; Horn, Tim; Pickett, Jim; Sharfstein, Joshua M.
• Editors: Johnson, Jeremiah; Killelea, Amy; Dangerfield, Derek T.; Beyrer, Chris; Sharfstein, Joshua M.
• Is Part Of: Journal of law, medicine & ethics. Volume 50(2022)Supplement 1
• Page Start: 8
• Page End: 23
• Publication Date: 2022
• Subjects: HIV -- PrEP -- Drug Pricing -- Access -- Federal Policy; Medical laws and legislation -- United States -- Periodicals; Medical care -- Law and legislation -- United States -- Periodicals; Medical ethics -- Periodicals; Jurisprudence -- Periodicals; Legislation, Medical -- Periodicals; Legislation, Nursing -- Periodicals; Ethics -- Periodicals; Forensic Medicine -- Periodicals; Nursing -- Periodicals; Medicine -- Periodicals; Societies -- Periodicals; Medical care -- Law and legislation; Medical ethics; Medical laws and legislation; United States; Periodicals; 344.73041
• DOI: 10.1017/jme.2022.30
• Languages: English
• ISSNs: 1073-1105

Abstract

Abstract: The U.S. has the tools to end the HIV epidemic, but progress has stagnated. A major gap in U.S. efforts to address HIV is the under-utilization of medications that can virtually eliminate acquisition of the virus, known as pre-exposure prophylaxis (PrEP). This document proposes a financing and delivery system to unlock broad access to PrEP for those most vulnerable to HIV acquisition and bring an end to the HIV epidemic.